home / stock / dxr / dxr news

DXR News and Press, Daxor Corporation From 09/24/19

Stock Information
Company Name: Daxor Corporation
Stock Symbol: DXR
Market: NYSE
Website: daxor.com
Menu
DXR DXR Quote DXR Short DXR News DXR Articles DXR Message Board
Get DXR Alerts

News, Short Squeeze, Breakout and More Instantly...
DXR - Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension

NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces new data demonstrating the clinical utility of the BVA-100 test...
DXR - New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor's Diagnostic Technology

NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces new data from the Mayo Clinic showing the benefits of the BVA techn...

DXR - Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America

NEW YORK, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces it will be attending the 23 rd Annual Scientific Meeting of the ...

DXR - Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019

NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, filed a Form N-CSR disclosing its schedule of portfolio holdings as of June 30, ...
DXR - Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest

NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces the acquisition of Daxor's BVA-100 blood volume analyzer as part...

DXR - Microcaps top midday movers

Gainers:  NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...

DXR - Daxor Corporation Announces New Research Initiative with Leading Hospital in the Southeast and the BVA-100® Blood Volume Diagnostic Test

NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces a new research initiative with a leading hospital in the Southea...
DXR - Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019

NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Michael Feldschuh, chief executive officer of Daxor Corporat...

DXR - Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice

NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces a new partnership with a leading hospital in North Carolina to in...

DXR - SBGI, AMG, GIII and ZNH among notable midday movers

Gainers:  Aquantia (NYSE: AQ ) +36% . Sinclair Broadcast (NASDAQ: SBGI ) +28% . Athenex (NASDAQ: ATNX ) +25% . Bridgeline Digital (NASDAQ: BLIN ) +22% . Regulus Therapeutics (NASDAQ: RGLS ) +18% . Ovid Therapeutics (NASDAQ: OVID ) +17% . Daxor Corporation (NYSEMKT: DXR ) +17% ....
Previous 10 Next 10